@article{ref1,
title="A model list of high risk drugs",
journal="Anales de Pediatria",
year="2013",
author="Cotrina Luque, J. and Guerrero Aznar, M. D. and Alvarez Del Vayo Benito, C. and Jimenez Mesa, E. and Guzman Laura, K. P. and Fernández Fernández, L.",
volume="79",
number="6",
pages="360-366",
abstract="INTRODUCTION: &quot;High-risk drugs&quot; are those that have a very high &quot;risk&quot; of causing death or serious injury if an error occurs during its use. The Institute for Safe Medication Practices (ISMP) has prepared a high-risk drugs list applicable to the general population (with no differences between the pediatric and adult population). Thus, there is a lack of information for the pediatric population. The main objective of this work is to develop a high-risk drug list adapted to the neonatal or pediatric population as a reference model for the pediatric hospital health workforce. MATERIAL AND METHODS: We made a literature search in May 2012 to identify any published lists or references in relation to pediatric and/or neonatal high-risk drugs. RESULTS: A total of 15 studies were found, from which 9 were selected. A model list was developed mainly based on the ISMP one, adding strongly perceived pediatric risk drugs and removing those where the pediatric use was anecdotal. CONCLUSIONS: There is no published list that suits pediatric risk management. The list of pediatric and neonatal high-risk drugs presented here could be a &quot;reference list of high-risk drugs &quot; for pediatric hospitals. Using this list and training will help to prevent medication errors in each drug supply chain (prescribing, transcribing, dispensing and administration).<p /> <p>Language: es</p>",
language="es",
issn="1695-4033",
doi="10.1016/j.anpedi.2013.04.026",
url="http://dx.doi.org/10.1016/j.anpedi.2013.04.026"
}